CNW/ - Pharmascience Canada is proud to announce the launch of  Pr  pms-RUPATADINE (rupatadine), a treatment that helps relieve nasal and non-nasal ...

More than 100 million Americans experience allergies to everyday exposures like pollen, mold and pet fur, according to data ...

Q4 2024 Management View CEO Stephan Tanda highlighted that Aptar achieved 2% core sales growth in Q4 2024 and delivered adjusted EPS of $1.52, exceeding the top end of guidance due to ...

KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...

There’s a cost that comes with the 450-percent increase in the price of EpiPens. Parents worry that they won’t be able to afford their child’s medication. They drive to ...

The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...

A woman who is living with over 40 allergies, including water, has shared how she has to use a colour-coded spread sheet to ...

Goodman also blamed "institutional inertia" and "circular reasoning" – that agencies had always experimented on animals – for not innovating outside animals, while Locke said feds were "passive and ...

ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...

Cal Yee Farms is recalling several of its popular chocolate treats due to a labeling mistake that could be deadly for people ...